KRAS G12C + KEAP1 mutation
|
NSCLC
|
KRAS G12C + KEAP1 mutation
|
NSCLC
|
Immunotherapy Resistant: C3 – Early Trials
|
Immunotherapy Resistant: C3 – Early Trials
|
KRAS G12C + KEAP1 mutation
|
NSCLC
|
KRAS G12C + KEAP1 mutation
|
NSCLC
|
sotorasib Resistant: C3 – Early Trials
|
sotorasib Resistant: C3 – Early Trials
|